| Authors: |
Lurvink RJ; Department of Surgical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, Netherlands., Bakkers C; Department of Surgical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, Netherlands., Rijken A; Department of Surgical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, Netherlands., van Erning FN; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Godebaldkwartier 319, 3511 DT, Utrecht, Netherlands., Nienhuijs SW; Department of Surgical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, Netherlands., Burger JW; Department of Surgical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623, Eindhoven, Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus Medical Center, Doctor Molewaterplein 40, 3015, Rotterdam, Netherlands., Lemmens VE; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Godebaldkwartier 319, 3511 DT, Utrecht, Netherlands., De Hingh IH; Department of Surgical Oncology, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht University, Universiteitssingel 40, 6229, Maastricht, Netherlands. Electronic address: ignace.d.hingh@catharinaziekenhuis.nl. |
